In this issue of JAMA, the reports by Maisel and colleagues1,2 and by Gould and Krahn3 represent substantial pieces of an information mosaic that is developing about life-sustaining and life-saving implantable arrhythmia device technologies. It is apparent, not only to the medical community, but also to patients, the press, regulators, investors, and the legal community, that this information mosaic is complex. The technologies are complex. The medical issues are complex. The ethical issues are complex. The financial issues are complex. No effort should trivialize this complexity or oversimplify and produce “the solution” without understanding that the information comes with gaps and never forms more than an incomplete mosaic. These 3 studies1- 3 provide new data to inform the most important issue—how physicians and patients should make individual decisions regarding pacemaker or implantable cardioverter-defibrillator (ICD) surgery.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 14
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.